DeepMed Research

BAXTER HEALTHCARE CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration

Not Applicable

Completed

Conditions: End Stage Renal Disease

Interventions: Device: FX800 Dialyzer
Device: Theranova 400 Dialyzer

First Posted Date: 2018-06-06

Last Posted Date: 2025-03-13

Lead Sponsor: Vantive Health LLC

Target Recruit Count: 212

Registration Number: NCT03547336

Locations: 🇨🇳
Investigational Site, Beijing, China

Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer

Not Applicable

Completed

Conditions: End Stage Renal Disease

Interventions: Device: FX80 Dialyzer
Device: Theranova 400 Dialyzer

First Posted Date: 2018-06-06

Last Posted Date: 2025-03-13

Lead Sponsor: Vantive Health LLC

Target Recruit Count: 156

Registration Number: NCT03547323

Locations: 🇨🇳
Investigational Site, Hangzhou, Zhejiang, China

Exploratory Study to Explore the Safety and Efficacy of the HDx Therapy Using Theranova 500 Dialyzer in Comparison to Hemodiafiltration

Not Applicable

Completed

Conditions: End Stage Renal Disease

Interventions: Device: Hemodiafiltration
Device: Theranova 500 medium cut-off dialyzer

First Posted Date: 2018-04-17

Last Posted Date: 2025-03-13

Lead Sponsor: Vantive Health LLC

Target Recruit Count: 43

Registration Number: NCT03499691

Locations: 🇪🇸
RTS Murcia VII, RTS Servicios de Diálisis S.L.U., Murcia, Spain

Validation of a Sensor for Non-Invasive Measurements

Completed

Conditions: CHF
Renal Disease
Hypertension

First Posted Date: 2018-03-13

Last Posted Date: 2022-01-20

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 136

Registration Number: NCT03463148

Locations: 🇺🇸
toSense, Inc. Headquarters, San Diego, California, United States

Hemopatch Compared to TachoSil in Postoperative Air Leak Duration After Pulmonary Resection

Not Applicable

Completed

Conditions: Air Leak From Lung

Interventions: Device: Hemopatch
Device: Tachosil

First Posted Date: 2018-03-01

Last Posted Date: 2020-04-06

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 279

Registration Number: NCT03450265

Locations: 🇪🇸
Baxter Investigational Site, Madrid, Spain

Hemopatch Performance Evaluation: A Prospective Observational Registry

Completed

Conditions: Dura Mater Nick Cut or Tear
Hemostatis
Air Leakage
Body Fluid Leakage

Interventions: Device: Hemopatch

First Posted Date: 2018-01-08

Last Posted Date: 2022-11-16

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 621

Registration Number: NCT03392662

Locations: 🇦🇹
Innsbruck Universitaetsklinik, Innsbruck, Austria
🇨🇿
Fakultní nemocnice u sv. Anny v Brně, Brno, Czechia
🇨🇿
Krajská Nemocnice Liberec, Liberec, Czechia

and more 12 locations

Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients

Not Applicable

Completed

Conditions: End Stage Renal Disease

Interventions: Device: Theranova 400 dialyzer
Device: Elisio-17H dialyzer

First Posted Date: 2017-08-22

Last Posted Date: 2025-03-13

Lead Sponsor: Vantive Health LLC

Target Recruit Count: 172

Registration Number: NCT03257410

Locations: 🇺🇸
DaVita Five Star Dialysis Center, Las Vegas, Nevada, United States
🇺🇸
DaVita Inc., Medical Center Dialysis, Houston, Texas, United States
🇺🇸
DaVita Inc., South Las Vegas Dialysis, Las Vegas, Nevada, United States

and more 17 locations

Remotely Monitoring Patients With Chronic Conditions in Their Home

Completed

Conditions: CHF

Interventions: Device: Discontinuation of using device

First Posted Date: 2017-07-05

Last Posted Date: 2019-09-10

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 36

Registration Number: NCT03207802

Locations: 🇺🇸
Elite Home Health, Texarkana, Arkansas, United States

Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery

Phase 3

Completed

Conditions: Cerebrospinal Fluid Leak

Interventions: Device: DuraSeal Dural Sealant
Drug: FS VH S/D 500 s-apr

First Posted Date: 2016-09-07

Last Posted Date: 2019-09-10

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 224

Registration Number: NCT02891070

Locations: 🇺🇸
University Hospitals Case Medical Center, Cleveland, Ohio, United States
🇪🇸
University Hospital 12 de Octubre, Madrid, Spain
🇪🇸
Hospital Clinic I Provincial de Barcelona, Barcelona, Spain

and more 22 locations

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

Phase 3

Terminated

Conditions: Regional Citrate Anticoagulation (RCA)
Continuous Renal Replacement Therapy (CRRT)
Acute Kidney Injury

Interventions: Drug: Prismocitrate 18
Other: No Anticoagulation

First Posted Date: 2016-08-09

Last Posted Date: 2025-03-13

Lead Sponsor: Vantive Health LLC

Target Recruit Count: 34

Registration Number: NCT02860130

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States

and more 9 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy